Dr. Crawford’s principle research interests lie in understanding how alterations in the ubiquitin proteasome system (UPS) contribute to the pathogenesis of Multiple Myeloma and applying this knowledge to identify opportunities for therapeutic intervention.
There are opportunities to investigate molecular mechanisms involved in dysregulation of the ubiquitin proteasome system in multiple myeloma and identify opportunities for therapeutic intervention.
PUBLIC OUTREACH AND KEY ACHIEVEMENTS
PhD Title: TRIM E3 ligases in Multiple Myeloma
Years of Study: 2014-2018
Current position: Randox
Our dedicated hub for postgraduate students, providing state-of-the-art facilities for study, and high-quality training and development programmes within a diverse interdisciplinary community.The gateway to your postgraduate experience
Queen's University Belfast is committed to Equality, Diversity and Inclusion.
For more information please read our Equality and Diversity Policy.
Queen's University Belfast is registered with the Charity Commission for Northern Ireland NIC101788
VAT registration number: GB 254 7995 11